| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |